According to Adaptive Biotechnologies
's latest financial reports the company has a price-to-book ratio of 1.22.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 2.30 | -2.26% |
2022-12-31 | 2.35 | -64.09% |
2021-12-31 | 6.56 | -39.75% |
2020-12-31 | 10.9 | 65.82% |
2019-12-31 | 6.56 | |
2018-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
HCA Healthcare HCA | 76.5 | 6,153.45% | ๐บ๐ธ USA |
Premier PINC | 1.05 | -14.14% | ๐บ๐ธ USA |
Community Health Systems
CYH | -0.5718 | -146.73% | ๐บ๐ธ USA |
Select Medical Holdings SEM | 2.24 | 82.66% | ๐บ๐ธ USA |